ANAPTYSBIO, INC. Stock Issued During Period, Shares, New Issues
ANAPTYSBIO, INC. (ANAB) had Stock Issued During Period, Shares, New Issues of 2.53 million shares as of 2018-09-28, per its 10-K filed 2021-02-25.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2021-02-25
- 2018-09-28: Stock Issued During Period, Shares, New Issues 2.53M shares.
- 2017-10-17: Stock Issued During Period, Shares, New Issues 3.00M shares.
| Period end | Stock Issued During Period, Shares, New Issues |
|---|---|
| 2018-09-28 | 2.53M shares 10-K · filed 2021-02-25 |
| 2017-10-17 | 3.00M shares 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |